HAEMONETICS CORP — Director's Dealing 2019

Apr 25, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2019-04-23

Reporting Person: Simon, Christopher (Director, President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-04-23	Common Stock	A	131050	—	Acquired	264317	Direct

Footnotes

F1: Represents shares earned from a performance share unit award granted to the reporting person on June 29, 2016, based on the issuer's total shareholder return relative to that of the companies comprising a blended index of the S&P MidCap 400 and S&P SmallCap 600 for the performance period from April 3, 2016 to March 30, 2019, as certified by the Compensation Committee of the Board of Directors on April 23, 2019. The award is subject to the reporting person's continued service through the vesting date of May 10, 2019.

F2: This number includes unvested restricted stock units previously reported as well as 141 shares purchased by the reporting person under the Issuer's 2007 Employee Stock Purchase Plan (as amended) on October 31, 2018.